Reoperation after oesophageal cancer surgery in relation to long-term survival: A population-based cohort study

BMJ Open

Volumn 4, Issue 3, 2014, Pages

  Van Der Schaaf, Maartje ^a   Derogar, Maryam ^a   Johar, Asif ^a   Rutegård, Martin ^a   Gossage, James ^b   Mason, Robert ^b   Lagergren, Pernilla ^a   Lagergren, Jesper ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HOSPITAL; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; REOPERATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SWEDEN; ADVERSE EFFECTS; EPIDEMIOLOGY; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REOPERATION; RETROSPECTIVE STUDIES; SWEDEN;

EID: 84897484447     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004648     Document Type: Article

References (30)

1. Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4:481-8. (Pubitemid 37009956)
2. Schieman C, Wigle DA, Deschamps C, et al. Patterns of operative mortality following esophagectomy. Dis Esophagus 2012;25:645-51.
3. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8:226-34. (Pubitemid 46291702)
4. Lerut T, Moons J, Coosemans W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg 2009;250:798-807.
5. Hirai T, Yamashita Y, Mukaida H, et al. Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 1998;28:576-9. (Pubitemid 28287698)
6. Ferri LE, Law S, Wong KH, et al. The influence of technical complications on postoperative outcome and survival after esophagectomy. Ann Surg Oncol 2006;13:557-64.
7. Rizk NP, Bach PB, Schrag D, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 2004;198:42-50. (Pubitemid 38201087)
8. Ancona E, Cagol M, Epifani M, et al. Surgical complications do not affect longterm survival after esophagectomy for carcinoma of the thoracic esophagus and cardia. J Am Coll Surg 2006;203:661-9. (Pubitemid 44648779)
9. Rutegard M, Lagergren P, Rouvelas I, et al. Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study. Ann Surg Oncol 2012;19:99-103.
10. Lagarde SM, de Boer JD, ten Kate FJW, et al. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg 2008;247:71-6.
11. Walker KG, Bell SW, Rickard MJ, et al. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 2004;240:255-9. (Pubitemid 38963016)
12. Derogar M, Sadr-Azodi O, Johar A, et al. Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study. J Clin Oncol 2013;31:551-7.
13. Rouvelas I, Zeng W, Lindblad M, et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 2005;6:864-70. (Pubitemid 41614798)
14. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27-33.
15. Lindblad M, Ye W, Lindgren A, et al. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg 2006;243:479-85.
16. Lagergren K, Derogar M. Validation of oesophageal cancer surgery data in the Swedish Patient Registry. Acta Oncol 2012;51:65-8.
17. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659-67.
18. Cohen JC, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum, 1983.
19. Grotenhuis BA, Wijnhoven BP, Grune F, et al. Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol 2010;101:270-8.
20. McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 2005;92:1150-4. (Pubitemid 41284881)
21. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-37. (Pubitemid 34984604)
22. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-27. (Pubitemid 37464537)
23. Brusselaers N, Mattsson F, Lagergren J. Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis. Gut 2013. Published Online First. doi:10.1136/gutjnl-2013-306074
24. Rouvelas I, Lagergren J. The impact of volume on outcomes after oesophageal cancer surgery. ANZ J Surg 2010;80:634-41.
25. Kassis ES, Kosinski AS, Ross P Jr, et al. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg 2013;96:1919-26.
26. Abramovitch R, Marikovsky M, Meir G, et al. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 1999;79:1392-8. (Pubitemid 29116795)
27. Tachibana M, Tabara H, Kotoh T, et al. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 1999;94:757-65. (Pubitemid 29124878)
28. Liu L, Wang Z, Jiang S, et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS ONE 2013;8:e64261.
29. Uccella S, Ghezzi F, Cromi A, et al. Perioperative allogenic blood transfusions and the risk of endometrial cancer recurrence. Arch Gynecol Obstet 2013;287:1009-16.
30. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 2012;256:235-44.